Actively Recruiting
Personalized Elevated Rate Pacing Treatment for Adults with Cardiac Amyloidosis and Pacemakers
Led by University of Minnesota · Updated on 2026-05-13
10
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating how heart failure symptoms and exercise tolerance change before and after increasing heart rate in patients with cardiac amyloidosis who already have pacemakers. This study focuses on a small group of 10 patients to better understand these improvements in their condition. Participants with cardiac amyloidosis and pacemakers will receive a personalized pacing protocol tailored to their height and heart function, specifically their left ventricular ejection fraction. This individualized pacing adjustment is designed to elevate the heart rate and assess its effects. During the study, researchers will measure heart failure symptoms using the Kansas City Cardiomyopathy Questionnaire and track any cardiovascular events over four months. Participants will be monitored closely, with assessments focused on heart function and symptom changes throughout the study period.
CONDITIONS
Brief Title
Elevated Rate Pacing of Cardiac Amyloidosis
Research Team
M
Meghan Muscala
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
